 |
市場調查報告書
商品編碼
2052319
乾癬性關節炎治療市場：按藥物類別、產品類型、給藥途徑、分銷管道和地區分類Psoriatic Arthritis Treatment Market, By Drug Class, By Product Type, By Route of Administration, By Distribution Channel, By Geography |
||||||
據估計，2026年乾癬性關節炎治療市場價值為134.1億美元，預計2033年將達到261.3億美元。預計從2026年到2033年，該市場將以10.0%的複合年成長率成長。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 134.1億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 10.00% | 2033年市場規模預測： | 261.3億美元 |
乾癬性關節炎是一種與銀屑病同時發生的慢性發炎性關節炎。據估計，約30%的乾癬患者會發展乾癬性關節炎。此疾病會導致關節及其周圍出現疼痛、僵硬和腫脹。隨著時間的推移，乾癬性關節炎可造成永久性關節損傷。傳統治療方法，包括使用緩解疾病抗風濕藥物（DMARDs，例如胺基甲基葉酸和TNF抑制劑）來控制症狀。全球乾癬性關節炎治療市場的成長主要得益於新型生物目標的研發和核准，這些藥物具有更高的安全性和有效性。
市場動態：
全球乾癬性關節炎治療市場的成長主要受乾癬性關節炎全球盛行率上升的驅動。據估計，該疾病的全球盛行率在0.06%至1%之間。此外，人們對該疾病的認知不斷提高以及先進治療方法的普及預計將進一步促進市場成長。然而，生物製藥的高成本可能成為市場成長的阻礙因素，尤其是在對價格敏感的發展中地區。市場相關人員持續致力於開發經濟實惠的生物製藥非專利藥，並有望在未來降低成本。此外，新興國家醫療保健支出的成長也可能在不久的將來為市場相關人員帶來新的機會。
本研究的主要特點：
本報告對全球乾癬性關節炎治療市場進行了詳細分析，顯示了以 2025 年為基準年，預測期（2026-2033 年）的市場規模（以十億美元計）和複合年成長率（%）。
本報告指出了各個細分市場的潛在商機，並說明了該市場中具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球乾癬性關節炎治療市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
本次調查涵蓋的主要公司包括輝瑞、強生、艾伯維、諾華、UCB、禮來和百時美施貴寶。
透過利用本報告中提出的見解，各公司的行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球乾癬性關節炎治療市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析全球乾癬性關節炎治療市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章：市場動態、監管與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 監管趨勢
- 產品上市及核准
- PEST分析
- 波特的分析
- 併購情景
第4章 全球乾癬性關節炎治療市場：依藥物類別分類，2021-2033年
- 生物製劑
- 非生物過程
- 聯合治療
第5章 全球乾癬性關節炎治療市場：依產品類型分類，2021-2033年
- 處方
- 非處方藥
第6章 全球乾癬性關節炎治療市場：依給藥途徑分類，2021-2033年
- 腸外
- 口服
第7章 全球乾癬性關節炎治療市場：依通路分類，2021-2033年
- 醫院藥房
- 零售藥房
- 網路藥房
第8章 全球乾癬性關節炎治療市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
- 非洲
- 南非
- 北非
- 中非
第9章 競爭情勢
- Medtronic
- Johnson & Johnson（DePuy Synthes）
- Zimmer Biomet
- Stryker
- Xtant Medical
- RTI Surgical
- SeaSpine
- Arthrex
- HansBioMed
- Exactech
- Wright Medical Group
- Bioventus
- Integra LifeSciences
- AlloSource
- Medline Industries
- Osiris Therapeutics
- Acelity
- Orthofix
- MTF Biologics
- Cerapedics
第10章 分析師建議
- 機會分析
- 分析師意見
- Coherent Opportunity Map
第11章 參考文獻與調查方法
- 參考
- 調查方法
- 關於本公司
Psoriatic Arthritis Treatment Market is estimated to be valued at USD 13.41 Bn in 2026 and is expected to reach USD 26.13 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 13.41 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.00% | 2033 Value Projection: | USD 26.13 Bn |
Psoriatic arthritis is a chronic inflammatory arthritis that occurs in conjunction with psoriasis. It is estimated that around 30% of people with psoriasis may develop psoriatic arthritis. The disease causes pain, stiffness and swelling in and around the joints. Over time, psoriatic arthritis can cause permanent damage to the joints. Conventional treatments including disease-modifying antirheumatic drugs (DMARDs) such as methotrexate and TNF inhibitors are used to manage the symptoms. Global psoriatic arthritis treatment market growth is driven by rising development and approval of novel targeted biologic therapies with better safety and efficacy profiles.
Market Dynamics:
Global psoriatic arthritis treatment market growth is driven by growing prevalence of psoriatic arthritis worldwide. According to estimates, the global prevalence of the disease ranges between 0.06% to 1%. Moreover, increasing awareness about the disease and availability of advanced treatments can also drive the market growth. However, high cost of biologic therapies can hamper the market growth, especially in price-sensitive developing regions. Continued efforts by market players to develop cost-effective generic versions of biologics can reduce costs over time. Furthermore, rising healthcare expenditures in emerging nations can offer new opportunities for the market players in the near future.
Key features of the study:
This report provides in-depth analysis of the global psoriatic arthritis treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global psoriatic arthritis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer, Johnson & Johnson, AbbVie, Novartis, UCB, Eli Lilly, Bristol-Myers Squibb
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global psoriatic arthritis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global psoriatic arthritis treatment market
Detailed Segmentation-
- Drug Class Insights (Revenue, USD Bn, 2021 - 2033)
- Biologics
- Non-biologics
- Combination Therapy
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Prescription
- Over-The-Counter (OTC)
- Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Parenteral
- Oral
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Medtronic
- Johnson & Johnson (DePuy Synthes)
- Zimmer Biomet
- Stryker
- Xtant Medical
- RTI Surgical
- SeaSpine
- Arthrex
- HansBioMed
- Exactech
- Wright Medical Group
- Bioventus
- Integra LifeSciences
- AlloSource
- Medline Industries
- Osiris Therapeutics
- Acelity
- Orthofix
- MTF Biologics
- Cerapedics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Psoriatic Arthritis Treatment Market, By Drug Class
- Global Psoriatic Arthritis Treatment Market, By Product Type
- Global Psoriatic Arthritis Treatment Market, By Route of Administration
- Global Psoriatic Arthritis Treatment Market, By Distribution Channel
- Global Psoriatic Arthritis Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Psoriatic Arthritis Treatment Market, By Drug Class, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Non-biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Combination Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Psoriatic Arthritis Treatment Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Prescription
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Over-The-Counter (OTC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Psoriatic Arthritis Treatment Market, By Route of Administration, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Psoriatic Arthritis Treatment Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Psoriatic Arthritis Treatment Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson (DePuy Synthes)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zimmer Biomet
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Stryker
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Xtant Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- RTI Surgical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SeaSpine
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Arthrex
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HansBioMed
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Exactech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Wright Medical Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bioventus
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Integra LifeSciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AlloSource
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medline Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Osiris Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Acelity
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Orthofix
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MTF Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cerapedics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
乾癬性關節炎治療市場規模、佔有率和成長分析：按藥物類別、給藥途徑、治療階段、分銷管道和地區分類－2026-2033年產業預測
乾癬性關節炎治療市場報告：按藥物類型、疾病類型、給藥途徑、分銷管道和地區分類（2026-2034 年）
全球乾癬性關節炎治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）
乾癬關節炎治療市場－全球產業規模、佔有率、趨勢、機會和預測（按藥物類別、給藥途徑、地區和競爭細分，2020-2030 年預測）
乾癬性關節炎治療市場規模、佔有率和趨勢分析報告：按藥物類別、類型、給藥途徑、地區和細分市場預測，2025 年至 2030 年